| Identification | Back Directory | [Name]
Semaglutide intermediate | [CAS]
1118767-15-9 | [Synonyms]
Fmoc-L-Lys[OctotBu)-Glu-(otBu)-AEEA-AEEA]-OSu
3,6,12,15-Tetraoxa-9,18,23-triazahentetracontanedioic acid, 22-[(1,1-dimethylethoxy)carbonyl]-10,19,24-trioxo-, 41-(1,1-dimethylethyl) 1-(2,5-dioxo-1-pyrrolidinyl) ester, (22S)- | [Molecular Formula]
C47H82N4O15 | [MDL Number]
MFCD32661370 | [MOL File]
1118767-15-9.mol | [Molecular Weight]
943.17 |
| Chemical Properties | Back Directory | [density ]
1.15±0.1 g/cm3(Predicted) | [pka]
14.18±0.46(Predicted) | [InChIKey]
ZYJILBKLUVJVKQ-QNGWXLTQSA-N | [SMILES]
C(ON1C(=O)CCC1=O)(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](C(OC(C)(C)C)=O)NC(=O)CCCCCCCCCCCCCCCCC(OC(C)(C)C)=O |
| Hazard Information | Back Directory | [Uses]
Semaglutide intermediate is an intermediate of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes.
|
|
|